TaleNeprilysin and Neprilysin inhibition in chronic kidney disease. (2021)
Attributed to:
Randomised trials in cardiovascular and metabolic disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/mnh.0000000000000659
PubMed Identifier: 33148948
Publication URI: http://europepmc.org/abstract/MED/33148948
Type: Journal Article/Review
Volume: 30
Parent Publication: Current opinion in nephrology and hypertension
Issue: 1
ISSN: 1062-4821